Imunon (IMNN) Other Non Operating Income (2011 - 2023)

Imunon (IMNN) has 13 years of Other Non Operating Income data on file, last reported at -$951227.0 in Q4 2023.

• Quarterly Other Non Operating Income rose 39.37% year-over-year to -$951227.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was -$2.8 million (up 3.44% YoY) and the FY2023 annual result came in at -$1.3 million, up 18.29% from the prior year.
• Other Non Operating Income slipped to -$951227.0 in Q4 2023, from -$329158.0 in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $1407.0 in Q1 2020 to a low of -$1.8 million in Q4 2020.
• A 5-year average of -$625182.4 and a median of -$234419.0 in 2021 frame the typical range for Other Non Operating Income.
• Annual changes were most pronounced in 2020 — Other Non Operating Income surged 5111.11% — and 2023, when it plunged 10972033.33%.
• Tracing IMNN's Other Non Operating Income over 5 years: stood at -$1.8 million in 2019, then slipped by 1.77% to -$1.8 million in 2020, then gained by 25.13% to -$1.4 million in 2021, then decreased by 13.52% to -$1.6 million in 2022, then surged by 39.37% to -$951227.0 in 2023.
• The last three Other Non Operating Income figures came in at -$951227.0 (Q4 2023), -$329158.0 (Q2 2023), and -$1.6 million (Q4 2022), per Business Quant data.